Alysse G Wurcel1, Julia Zubiago2, Jessica Reyes2, Emma Smyth2, Keki R Balsara3, Danielle Avila4, Joshua A Barocas5, Curt G Beckwith6, Jenny Bui7, Cody A Chastain3, Ellen F Eaton4, Simeon Kimmel8, Molly L Paras9, Asher J Schranz10, Darshali A Vyas9, Alison Rapoport11. 1. Tufts Medical Center, Boston, Massachusetts. Electronic address: awurcel@tuftsmedicalcenter.org. 2. Tufts Medical Center, Boston, Massachusetts. 3. Vanderbilt University Medical Center, Nashville, Tennessee. 4. University of Alabama at Birmingham, Birmingham, Alabama. 5. Divisions of Internal Medicine and Infectious Diseases, University of Colorado, Denver, Colorado. 6. Division of Infectious Diseases, Alpert Medical School of Brown University/The Miriam Hospital, Providence, Rhode Island. 7. Department of Surgery, Henry Ford Health System, Detroit, Michigan. 8. Section of General Internal Medicine/Infectious Diseases, Boston Medical Center, Boston, Massachusetts. 9. Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. 10. University of North Carolina School of Medicine, Chapel Hill, North Carolina. 11. Cambridge Health Alliance, Cambridge, Massachusetts.
Abstract
BACKGROUND: Hospitalizations for drug-use associated infective endocarditis (DUA-IE) have led to increasing surgical consultation for valve replacement. Cardiothoracic surgeons' perspectives about the process of decision making around operation for people with DUA-IE are largely unknown. METHODS: This multisite semiqualitative study sought to gather the perspectives of cardiothoracic surgeons on initial and repeat valve surgery for people with DUA-IE through purposeful sampling of surgeons at 7 hospitals: University of Alabama, Tufts Medical Center, Boston Medical Center, Massachusetts General Hospital, University of North Carolina-Chapel Hill, Vanderbilt University Medical Center, and Rhode Island Hospital-Brown University. RESULTS: Nineteen cardiothoracic surgeons (53% acceptance) were interviewed. Perceptions of the drivers of addiction varied as well as approaches to repeat valve operations. There were mixed views on multidisciplinary meetings, although many surgeons expressed an interest in more efficient meetings and more intensive postoperative and posthospitalization multidisciplinary care. CONCLUSIONS: Cardiothoracic surgeons are emotionally and professionally impacted by making decisions about whether to perform valve operation for people with DUA-IE. The use of efficient, agenda-based multidisciplinary care teams is an actionable solution to improve cross-disciplinary partnerships and outcomes for people with DUA-IE.
BACKGROUND: Hospitalizations for drug-use associated infective endocarditis (DUA-IE) have led to increasing surgical consultation for valve replacement. Cardiothoracic surgeons' perspectives about the process of decision making around operation for people with DUA-IE are largely unknown. METHODS: This multisite semiqualitative study sought to gather the perspectives of cardiothoracic surgeons on initial and repeat valve surgery for people with DUA-IE through purposeful sampling of surgeons at 7 hospitals: University of Alabama, Tufts Medical Center, Boston Medical Center, Massachusetts General Hospital, University of North Carolina-Chapel Hill, Vanderbilt University Medical Center, and Rhode Island Hospital-Brown University. RESULTS: Nineteen cardiothoracic surgeons (53% acceptance) were interviewed. Perceptions of the drivers of addiction varied as well as approaches to repeat valve operations. There were mixed views on multidisciplinary meetings, although many surgeons expressed an interest in more efficient meetings and more intensive postoperative and posthospitalization multidisciplinary care. CONCLUSIONS: Cardiothoracic surgeons are emotionally and professionally impacted by making decisions about whether to perform valve operation for people with DUA-IE. The use of efficient, agenda-based multidisciplinary care teams is an actionable solution to improve cross-disciplinary partnerships and outcomes for people with DUA-IE.
Authors: Gösta B Pettersson; Joseph S Coselli; Gösta B Pettersson; Joseph S Coselli; Syed T Hussain; Brian Griffin; Eugene H Blackstone; Steven M Gordon; Scott A LeMaire; Laila E Woc-Colburn Journal: J Thorac Cardiovasc Surg Date: 2017-01-24 Impact factor: 5.209
Authors: Sami El-Dalati; Irina Khurana; Nathaniel Soper; Daniel Cronin; Michael Shea; Richard L Weinberg; James Riddell; Laraine Washer; Emily Shuman; James Burke; Sadhana Murali; D Alexander Perry; Christopher Fagan; Twisha Patel; Kirra Ressler; George Michael Deeb Journal: Eur J Clin Microbiol Infect Dis Date: 2019-12-14 Impact factor: 3.267
Authors: J Michael DiMaio; Tomas A Salerno; Ron Bernstein; Katia Araujo; Marco Ricci; Robert M Sade Journal: Ann Thorac Surg Date: 2009-07 Impact factor: 4.330
Authors: Kevin R An; Jessica G Y Luc; Derrick Y Tam; Olina Dagher; Rachel Eikelboom; Joel Bierer; Andréanne Cartier; Thin X Vo; Olivier Vaillancourt; Keir Forgie; Malak Elbatarny; Sophie Weiwei Gao; Richard Whitlock; Wiplove Lamba; Rakesh C Arora; Corey Adams; Bobby Yanagawa Journal: Ann Thorac Surg Date: 2021-01-06 Impact factor: 4.330
Authors: Alison B Rapoport; Leah S Fischer; Scott Santibanez; Susan E Beekmann; Philip M Polgreen; Christopher F Rowley Journal: Open Forum Infect Dis Date: 2018-06-08 Impact factor: 3.835
Authors: Edward F Gibbons; Gary Huang; Gabriel Aldea; Kevin Koomalsingh; Jared W Klein; Shireesha Dhanireddy; Robert Harrington Journal: Crit Pathw Cardiol Date: 2020-12
Authors: Yoelkys Morales; Emma Smyth; Julia Zubiago; Benjamin Bearnot; Alysse G Wurcel Journal: Open Forum Infect Dis Date: 2022-10-19 Impact factor: 4.423